DSM Biomedical has appointed Eric Teutsch as president, effective from 16 February 2016. Teutsch has taken over the role from Gerard de Reuver, who has served as the company’s interim president since November 2015.
Teutsch will supervise the strategic development and execution of DSM’s international activities, according to a company release. The company aims to strengthen existing technology platforms and explore opportunities to form strategic partnerships to further its activities in the medical device industry.
“I am honoured to have been appointed president of DSM Biomedical,” says Teutsch. “I am excited to drive expansion and solidify our position as the market leader.”
Teutsch joins DSM from Stryker, where he was vice president and general manager of the Orthobiologics Division. In his nearly 30 years at Stryker, Teutsch led the acquisition, integration and operation of ten new product lines and businesses and led four new stand-alone business divisions.